The closing price of Cerevel Therapeutics Holdings Inc. (NASDAQ: CERE) was $33.27 for the day, down -2.15% from the previous closing price of $34.00. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 638687 shares were traded. CERE stock price reached its highest trading level at $35.06 during the session, while it also had its lowest trading level at $33.00.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Our analysis of CERE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.40 and its Current Ratio is at 13.40. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.78.
Upgrades & Downgrades
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 04 when COLES N ANTHONY sold 50,000 shares for $31.47 per share. The transaction valued at 1,573,434 led to the insider holds 2,704 shares of the business.
COLES N ANTHONY sold 50,000 shares of CERE for $1,253,130 on Apr 11. The CEO and Chairperson now owns 2,704 shares after completing the transaction at $25.06 per share. On Mar 03, another insider, COLES N ANTHONY, who serves as the CEO and Chairperson of the company, sold 3,000 shares for $27.19 each. As a result, the insider received 81,570 and left with 2,704 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CERE now has a Market Capitalization of 4.92B and an Enterprise Value of 4.46B.
Stock Price History:
Over the past 52 weeks, CERE has reached a high of $41.46, while it has fallen to a 52-week low of $22.10. The 50-Day Moving Average of the stock is 27.58, while the 200-Day Moving Average is calculated to be 29.25.
CERE traded an average of 636.90K shares per day over the past three months and 478.04k shares per day over the past ten days. A total of 156.65M shares are outstanding, with a floating share count of 128.77M. Insiders hold about 17.56% of the company’s shares, while institutions hold 86.00% stake in the company. Shares short for CERE as of Apr 27, 2023 were 4.46M with a Short Ratio of 4.46M, compared to 5.32M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.84% and a Short% of Float of 10.12%.
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.67 for the current quarter, with a high estimate of -$0.54 and a low estimate of -$0.84, while EPS last year was -$0.62. The consensus estimate for the next quarter is -$0.7, with high estimates of -$0.58 and low estimates of -$0.91.
Analysts are recommending an EPS of between -$1.48 and -$3.5 for the fiscal current year, implying an average EPS of -$2.62. EPS for the following year is -$2.81, with 10 analysts recommending between -$2.54 and -$3.64.